# Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

> **NCT01037855** · — · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 4028 (actual)

## Conditions studied

- Novel Influenza A (H1N1)
- A New Flu Virus of Swine Origin

## Interventions

- **OTHER:** Non-intervention observational study

## Key facts

- **NCT ID:** NCT01037855
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-06
- **Final completion:** 2011-01
- **Target enrollment:** 4028 (ACTUAL)
- **Last updated:** 2017-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037855, "Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01037855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*